ConductScience.org, home

Paper73669

Anti-e in primary hepatic carcinoma.

Werner BG and 3 others. Lancet, 1976. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anti-e in primary hepatic carcinoma. Papers, record 73669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73669

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-e in primary hepatic carcinoma.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Letter, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.42
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Werner BGB G
2Murphy BLB L
3Maynard JEJ E
4Larouzé BB

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Hepatitis B AntibodiesMajor topic
Liver NeoplasmsMajor topic
Animals
Carrier State
Chronic Disease
Hepatitis B Antigens
Liver Cirrhosis
Mali
Mice
Senegal

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
6,324,594Immunopathologic aspects of woodchuck hepatitis.Am J Pathol1984https://conductscience.org/library/papers/6324594PubMed
3,457,384A newly identified hepatitis B type virus in tree squirrels.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3457384PubMed
310,427T-lymphocytes and hepatitis B serology.Infection1978https://conductscience.org/library/papers/310427PubMed
266,209Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/266209PubMed
230,994Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.Gastroenterol Jpn1979https://conductscience.org/library/papers/230994PubMed
211,144Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.J Clin Microbiol1978https://conductscience.org/library/papers/211144PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/73669

GET https://conductscience.org/api/papers/v1/73669/authors